FSD Pharma Inc.

NASDAQ:HUGE

0.09 (USD) • At close August 14, 2024
Bedrijfsnaam FSD Pharma Inc.
Symbool HUGE
Munteenheid USD
Prijs 0.09
Beurswaarde 66,671
Dividendpercentage 0%
52-weken bereik 0.087 - 109.193
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Zeeshan Saeed
Website https://www.fsdpharma.com

An error occurred while fetching data.

Over FSD Pharma Inc.

FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such as

Vergelijkbare Aandelen

Avalo Therapeutics, Inc. logo

Avalo Therapeutics, Inc.

AVTX

9.371 USD

Immix Biopharma, Inc. logo

Immix Biopharma, Inc.

IMMX

1.77 USD

Microbot Medical Inc. logo

Microbot Medical Inc.

MBOT

0.883 USD

Regulus Therapeutics Inc. logo

Regulus Therapeutics Inc.

RGLS

1.71 USD

T2 Biosystems, Inc. logo

T2 Biosystems, Inc.

TTOO

2.2 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)